MHC class II-transfected tumor cells directly present antigen to tumor- specific CD4+ T lymphocytes

Journal of Immunology

Volumn 160, Issue 2, 1998, Pages 661-666

  Armstrong, Todd D ^b   Clements, Virginia K ^b   Ostrand Rosenberg, Suzanne ^a,b  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; HELPER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR CELL CULTURE; TUMOR IMMUNITY; VACCINATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED A; MICE, INBRED C57BL; MURAMIDASE; PEPTIDE FRAGMENTS; RADIATION CHIMERA; SARCOMA, EXPERIMENTAL; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031963995     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Chen, L., S. Ashe, W. A. Brady, I. Hellstrom, K. E. Hellstrom, J. A. Ledbetter, P. McGowan, and P. S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093.
2. Chen, L., P. S. Linsley, and K. E. Hellstrom. 1993. Co-stimulation of T cells for tumor immunity. Immunol. Today 14:483.
3. + T cells by B7-transfected melanoma cells. Science 259:368.
4. Baskar, S., S. Ostrand-Rosenberg, N. Nabavi, L. M. Nadler, G. J. Freeman, and L. H. Glimcher. 1993. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 90:5687.
5. Fearon, E., D. Pardoll, T. Itaya, P. Golumbek, H. Levitsky, J. Simons, H. Karasuyama, B. Vogelslein, and P. Frost. 1990. IL-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397.
6. Golumbek, P., A. Lazenby, H. Levitsky, L. Jaffee, H. Karasuyama, M. Baker, and D. Pardoll. 1991. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713.
7. Ostrand-Rosenberg, S., A. Thakur, and V. Clements. 1990. Rejection of mouse sarcoma cells after transfection of MHC class II genes. J. Immunol. 144:4068.
8. Ostrand-Rosenberg, S. 1994. Tumor immunotherapy: the tumor cell as an antigen-presenting cell. Curr. Opin. Immunol. 6:722.
9. James, R., S. Edwards, K. Hui, P. Bassett, and F. Grosveld. 1991. The effect of class II gene transfection on the tumorigenicity of the H-2K negative mouse leukemia cell line K36.16. Immunology 72:213.
10. + T lymphocytes by murine melanoma cells transfected with major histocompatibility complex class II genes. J. Leukocyte Biol. 56:469.
11. Chen, P., and H. Ananthaswamy. 1993. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2. J. Immunol. 151:244.
12. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med. 181:619.
13. Bevan, M. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283.
14. Bevan, M. 1976. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117:2233.
15. Ostrand-Rosenberg, S., and A. Cohn. 1981. H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells. Proc. Natl. Acad. Sci. USA 78:7106.
16. Ozato, K., N. Mayer, and D. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533.
17. Ozato, K., and D. Sachs. 1981. Monoclonal antibodies to mouse MHC antigens. J. Immunol. 126:317.
18. Landais, D., B. Beck, J. Buerstedde, S. Degraw, D. Klein, N. Koch, D. Murphy, M. Pierres, T. Tada, K. Yamamoto, C. Benoist, and D. Mathis. 1986. The assignment of chain specificities for anti-Ia monoclonal antibodies using L cell transfectants. J. Immunol. 137:3002.
19. Armstrong, T., V. Clements, B. Martin, J. P.-Y. Ting, and S. Ostrand-Rosenberg. 1997. Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc. Natl. Acad. Sci. USA 120:123.
20. k-restricted T helper hybridomas. J. Immunol. 142:3298.
21. Shastri, N., A. Oki, A. Miller, and E. Sercarz. 1985. Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins. J. Exp. Med. 162:332.
22. Ostrand-Rosenberg, S., V. Clements, and L. Marr. 1986. 402AX teratocarcinoma MHC class I antigen expression is regulated in vivo by Lyt1, Lyt2, and L3T4 expressing splenic T cells. Cell. Immunol. 98:257.
23. Oi, V., P. Jones, J. Goding, L. Herzenberg, and L. Herzenberg. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr. Top. Microbiol. Immunol. 81:115.
24. Ozato, K., N. Mayer, and D. Sachs. 1982. Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation 34:113.
25. Smith-Gill, S., T. Lavoie, and C. Mainhart. 1984. Antigenic regions defined by monoclonal antibodies correspond to structural domains of avian lysozyme. J. Immunol. 133:384.
26. Allen, P., D. Strydom, and E. Unanue. 1984. Processing of lysozyme by macrophages: identification of determinant recognized by two T-cell hybridomas. Proc. Natl. Acad. Sci. USA 81:2489.
27. Gammon, G., H. Geysen, R. Apple, E. Pickett, M. Palmer, A. Ametani, and E. Sercarz. 1991. T cell determinant structure: cores and determinant envelopes in three mouse MHC haplotypes. J. Exp. Med. 173:609.
28. Moudgil, K., and E. Sercarz. 1993. Dominant determinants in hen eggwhite lysozyme correspond to the cryptic determinants within its self-homologue, mouse lysozyme. J. Exp. Med. 178:2131.
29. Lenschow, D., T. Walunas, and J. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
30. Baskar, S., V. Clements, L. Glimcher, N. Nabavi, and S. Ostrand-Rosenberg. 1996. Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules. J. Immunol. 156:3821.
31. Ostrand-Rosenberg, S., S. Baskar, N. Parterson, and V. Clements. 1996. Expression of MHC class II and B7-1 and B7-2 costimulatory molecules accompanies tumor rejection and reduces the metastatic potential of tumor cells. Tissue Antigens 47:414.
32. Lanzavecchia, A. 1996. Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 8:348.
33. Yang, G., M. Mizuno, K. Hellstrom, and L. Chen. 1997. B7-negative versus B7-positive P815 tumor: differential requirements for priming of an antitumor immune response in lymph nodes. J. Immunol. 158:851.
34. Cayeux, S., G. Richter, G. Noffz, B. Dorken, and T. Blankenstein. 1997. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J. Immunol. 158:2834.
35. Pulaski, B., K. Yeh, N. Shastri, K. Maltby, D. Penney, E. Lord, and J. Frelinger. 1996. IL-3 enhances CTL development and class I MHC presentation of exogenous antigen by tumor-infiltrating macrophages. Proc. Natl. Acad. Sci. USA 93:3669.
36. Huang, A., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
37. Huang, A., A. Bruce, D. Pardoll, and H. Levitsky. 1996. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J. Exp. Med. 183:769.
38. Kundig, T., M. Bachmann, C. DiPaolo, J. Simard, M. Battegay, H. Lother, A. Gessner, K. Kuhlcke, P. Ohashi, H. Hengartner, and R. Zinkernagel. 1995. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268: 1343.